New recovery blueprint aims to get cancer patients home faster

NCT ID NCT07493876

Recruiting now Knowledge-focused Sponsor: Fondazione del Piemonte per l'Oncologia Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a structured recovery plan called ERAS helps people recover faster after surgery for cancer that has spread in the abdomen. About 300 patients across 20 Italian hospitals will be followed. The plan includes steps before, during, and after surgery to reduce stress and speed healing. The main goal is to see if it shortens hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Enhanced Recovery After Surgery (ERAS) protocol
What this could lead to: If successful, this could show that a standardized care pathway reduces hospital stays and complications for patients undergoing major abdominal cancer surgery.
What could go wrong: This is an early-stage observational study comparing before-and-after care, not a randomized trial. Results may not prove the protocol itself causes improvement, and individual patient factors vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peritoneal carcinomatosis peritoneal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERITONEAL CARCINOMATOSIS

Contacts and locations

Locations

Fondazione IRCCS Policlinico San Matteo
NOT_YET_RECRUITING

Pavia, Italy
Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo
RECRUITING

Candiolo, Turin, 10060, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.